Joyce Okawa

2.7k total citations
39 papers, 1.6k citations indexed

About

Joyce Okawa is a scholar working on Rheumatology, Epidemiology and Immunology. According to data from OpenAlex, Joyce Okawa has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Rheumatology, 17 papers in Epidemiology and 16 papers in Immunology. Recurrent topics in Joyce Okawa's work include Inflammatory Myopathies and Dermatomyositis (15 papers), Systemic Lupus Erythematosus Research (15 papers) and T-cell and B-cell Immunology (8 papers). Joyce Okawa is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (15 papers), Systemic Lupus Erythematosus Research (15 papers) and T-cell and B-cell Immunology (8 papers). Joyce Okawa collaborates with scholars based in United States, Australia and Japan. Joyce Okawa's co-authors include Victoria P. Werth, Lynne Taylor, Andrea B. Troxel, Rui Feng, Siamak Moghadam‐Kia, Rachel S. Klein, Kathleen J. Propert, Inbal Braunstein, David Fiorentino and Christopher M. Coley and has published in prestigious journals such as Neurology, Annals of the Rheumatic Diseases and Journal of Investigative Dermatology.

In The Last Decade

Joyce Okawa

39 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joyce Okawa United States 27 1.1k 600 533 358 269 39 1.6k
Silvano Bettio Italy 16 905 0.8× 681 1.1× 254 0.5× 239 0.7× 84 0.3× 20 1.5k
Mariaelisa Rampudda Italy 11 625 0.6× 402 0.7× 383 0.7× 194 0.5× 86 0.3× 15 1.2k
Mittermayer B. Santiago Brazil 20 1.3k 1.2× 659 1.1× 166 0.3× 321 0.9× 70 0.3× 65 1.8k
Yasuhiro Shimojima Japan 21 661 0.6× 494 0.8× 454 0.9× 114 0.3× 79 0.3× 135 1.8k
Kalliopi Fragiadaki Greece 18 686 0.6× 437 0.7× 103 0.2× 234 0.7× 88 0.3× 26 1.4k
Stephen Xu United States 25 1.2k 1.1× 657 1.1× 246 0.5× 173 0.5× 133 0.5× 61 1.7k
NJ McHugh United Kingdom 9 530 0.5× 236 0.4× 581 1.1× 125 0.3× 127 0.5× 16 903
M. N. Manoussakis Greece 17 620 0.6× 314 0.5× 192 0.4× 227 0.6× 59 0.2× 22 1.1k
A J Silman United Kingdom 15 741 0.7× 277 0.5× 191 0.4× 416 1.2× 177 0.7× 22 1.6k
Diane Koontz United States 14 505 0.5× 242 0.4× 990 1.9× 181 0.5× 162 0.6× 18 1.1k

Countries citing papers authored by Joyce Okawa

Since Specialization
Citations

This map shows the geographic impact of Joyce Okawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce Okawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce Okawa more than expected).

Fields of papers citing papers by Joyce Okawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joyce Okawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce Okawa. The network helps show where Joyce Okawa may publish in the future.

Co-authorship network of co-authors of Joyce Okawa

This figure shows the co-authorship network connecting the top 25 collaborators of Joyce Okawa. A scholar is included among the top collaborators of Joyce Okawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyce Okawa. Joyce Okawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Werth, Victoria P., S.M. Peña, Majid Zeidi, et al.. (2022). Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial. Journal of Investigative Dermatology. 142(10). 2651–2659.e1. 37 indexed citations
2.
Maddukuri, Spandana, Jay Patel, Maria Wysocka, et al.. (2022). Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM. Arthritis Research & Therapy. 24(1). 12–12. 18 indexed citations
3.
Bax, Christina E., Madison Grinnell, Josef Symon S. Concha, et al.. (2022). Frequency of immunostimulatory herbal supplement use among patients with autoimmune skin disease. Journal of the American Academy of Dermatology. 87(5). 1093–1095. 6 indexed citations
4.
Werth, Victoria P., Donna A. Culton, Josef Symon S. Concha, et al.. (2021). Safety, Tolerability, and Activity of ALXN1830 Targeting the Neonatal Fc Receptor in Chronic Pemphigus. Journal of Investigative Dermatology. 141(12). 2858–2865.e4. 32 indexed citations
5.
Pearson, David R., et al.. (2020). Malignancy in dermatomyositis: A retrospective study of 201 patients seen at the University of Pennsylvania. Journal of the American Academy of Dermatology. 83(1). 117–122. 18 indexed citations
6.
Okawa, Joyce, et al.. (2020). Evaluating the effect of prior authorizations in patients with complex dermatologic conditions. Journal of the American Academy of Dermatology. 83(6). 1674–1680. 11 indexed citations
7.
Werth, Victoria P., David R. Pearson, Joyce Okawa, et al.. (2019). 610 Safety and efficacy of lenabasum in refractory skin-predominant dermatomyositis subjects treated on an open-label extension of trial JBT101-DM-001. Journal of Investigative Dermatology. 139(5). S105–S105. 5 indexed citations
8.
Chang, Aileen Y., et al.. (2013). Characterization of clinical photosensitivity in cutaneous lupus erythematosus. Journal of the American Academy of Dermatology. 69(2). 205–213. 51 indexed citations
9.
Goreshi, Renato, Joyce Okawa, Rui Feng, et al.. (2012). Evaluation of Reliability, Validity, and Responsiveness of the CDASI and the CAT-BM. Journal of Investigative Dermatology. 132(4). 1117–1124. 36 indexed citations
10.
Braunstein, Inbal, Noah Goodman, Misha Rosenbach, et al.. (2011). Lenalidomide therapy in treatment-refractory cutaneous lupus erythematosus: Histologic and circulating leukocyte profile and potential risk of a systemic lupus flare. Journal of the American Academy of Dermatology. 66(4). 571–582. 40 indexed citations
11.
Klein, Rachel S., Siamak Moghadam‐Kia, Joyce Okawa, et al.. (2011). Development of the CLASI as a Tool to Measure Disease Severity and Responsiveness to Therapy in Cutaneous Lupus Erythematosus. Archives of Dermatology. 147(2). 203–203. 132 indexed citations
12.
Goreshi, Renato, et al.. (2011). Quality of life in dermatomyositis. Journal of the American Academy of Dermatology. 65(6). 1107–1116. 76 indexed citations
13.
Kreider, Mary Elizabeth, et al.. (2010). Interstitial Lung Disease in Classic and Skin-Predominant Dermatomyositis. Archives of Dermatology. 146(7). 729–38. 40 indexed citations
14.
Moghadam‐Kia, Siamak, et al.. (2009). Cross-sectional Analysis of a Collaborative Web-Based Database for Lupus Erythematosus–Associated Skin Lesions. Archives of Dermatology. 145(3). 255–60. 38 indexed citations
15.
Shah, Asha, Joerg Albrecht, Joyce Okawa, et al.. (2009). Lenalidomide for the Treatment of Resistant Discoid Lupus Erythematosus. Archives of Dermatology. 145(3). 303–6. 36 indexed citations
16.
Fiorentino, David, Joyce Okawa, Lynne Taylor, et al.. (2009). Modification of the Cutaneous Dermatomyositis Disease Area and Severity Index, an outcome instrument. British Journal of Dermatology. 162(3). 669–673. 53 indexed citations
17.
Albrecht, Joerg, et al.. (2008). The Cutaneous Lupus Erythematosus Disease Area and Severity Index. Archives of Dermatology. 144(2). 173–80. 70 indexed citations
18.
Klein, Rhonda Q., Melissa Costner, M. Kari Connolly, et al.. (2008). Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis. British Journal of Dermatology. 159(4). 887–894. 62 indexed citations
19.
Krathen, Michael, Jonathan Dunham, Jacqueline M. Junkins‐Hopkins, et al.. (2008). The cutaneous lupus erythematosus disease activity and severity index: Expansion for rheumatology and dermatology. Arthritis Care & Research. 59(3). 338–344. 41 indexed citations
20.
Ances, Beau M., Anne Roc, Marc Korczykowski, et al.. (2006). Caudate blood flow and volume are reduced in HIV + neurocognitively impaired patients. Neurology. 66(6). 862–866. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvano Bettio Breakdown of academic impact, for papers by Mariaelisa Rampudda Breakdown of academic impact, for papers by Mittermayer B. Santiago Breakdown of academic impact, for papers by Yasuhiro Shimojima Breakdown of academic impact, for papers by Kalliopi Fragiadaki Breakdown of academic impact, for papers by Stephen Xu Breakdown of academic impact, for papers by NJ McHugh Breakdown of academic impact, for papers by M. N. Manoussakis Breakdown of academic impact, for papers by A J Silman Breakdown of academic impact, for papers by Diane Koontz
Rankless by CCL
2026